SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011770
Filing Date
2022-08-03
Accepted
2022-08-03 08:30:56
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20220630x10q.htm   iXBRL 10-Q 1253199
2 EX-31.1 glyc-20220630xex31d1.htm EX-31.1 16951
3 EX-31.2 glyc-20220630xex31d2.htm EX-31.2 16767
4 EX-32.1 glyc-20220630xex32d1.htm EX-32.1 9430
  Complete submission text file 0001558370-22-011770.txt   5229291

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20220630.xsd EX-101.SCH 33718
6 EX-101.CAL glyc-20220630_cal.xml EX-101.CAL 36034
7 EX-101.DEF glyc-20220630_def.xml EX-101.DEF 156951
8 EX-101.LAB glyc-20220630_lab.xml EX-101.LAB 338469
9 EX-101.PRE glyc-20220630_pre.xml EX-101.PRE 275986
53 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220630x10q_htm.xml XML 866968
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 221131039
SIC: 2834 Pharmaceutical Preparations